Shares of Staar Surgical Co. (NASDAQ:STAA) were up 3.6% on Friday . The stock traded as high as $8.69 and last traded at $8.56, with a volume of 64,736 shares traded. The stock had previously closed at $8.26.

Several analysts have recently weighed in on STAA shares. William Blair reissued a “market perform” rating on shares of Staar Surgical in a report on Thursday, August 4th. Zacks Investment Research raised Staar Surgical from a “hold” rating to a “buy” rating and set a $9.50 price objective on the stock in a report on Saturday, August 6th. Canaccord Genuity reissued a “hold” rating and set a $7.00 price objective on shares of Staar Surgical in a report on Thursday, May 12th. Stephens lowered Staar Surgical from an “overweight” rating to an “equal weight” rating in a report on Thursday, May 12th. Finally, Benchmark Co. raised Staar Surgical from a “hold” rating to a “buy” rating and set a $6.00 price objective on the stock in a report on Wednesday, May 18th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Staar Surgical has an average rating of “Hold” and a consensus target price of $7.50.

The company’s 50 day moving average is $6.54 and its 200 day moving average is $6.62. The company’s market cap is $357.01 million.

Staar Surgical (NASDAQ:STAA) last issued its quarterly earnings results on Wednesday, August 3rd. The company reported ($0.05) EPS for the quarter, meeting the consensus estimate of ($0.05). The company had revenue of $21 million for the quarter, compared to analyst estimates of $19.88 million. Staar Surgical’s revenue was up 12.4% compared to the same quarter last year. On average, equities research analysts forecast that Staar Surgical Co. will post ($0.31) earnings per share for the current year.

In other Staar Surgical news, major shareholder Broadwood Partners Lp acquired 336,210 shares of the company’s stock in a transaction on Monday, May 16th. The shares were purchased at an average price of $5.49 per share, for a total transaction of $1,845,792.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard A. Meier sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, May 20th. The shares were sold at an average price of $5.35, for a total value of $133,750.00. Following the completion of the sale, the director now owns 27,149 shares in the company, valued at approximately $145,247.15. The disclosure for this sale can be found here.

A hedge fund recently raised its stake in Staar Surgical stock. Mutual of America Capital Management LLC raised its stake in shares of Staar Surgical Co. (NASDAQ:STAA) by 0.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 216,682 shares of the company’s stock after buying an additional 1,299 shares during the period. Mutual of America Capital Management LLC owned approximately 0.54% of Staar Surgical worth $1,547,000 as of its most recent SEC filing.

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.